Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 17Leukemia, Lymphocytic, Chronic, B-Cell 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Hodgkin Disease 15Multiple Myeloma 12Lymphoma, Non-Hodgkin 11Myelodysplastic Syndromes 10Lymphoma, Mantle-Cell 10Myeloproliferative Disorders 9Leukemia, Myelomonocytic, Chronic 9Leukemia, Myeloid, Chronic-Phase 9Waldenstrom Macroglobulinemia 8Lymphoma, Large B-Cell, Diffuse 8Leukemia, Prolymphocytic 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Myelodysplastic-Myeloproliferative Diseases 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Anemia, Refractory, with Excess of Blasts 6Leukemia 5Burkitt Lymphoma 5Recurrence 4Primary Myelofibrosis 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma 4Leukemia, Prolymphocytic, T-Cell 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Graft vs Host Disease 4Congenital Abnormalities 4Blast Crisis 4

Interventions

fludarabine phosphate 5Melphalan 5Whole-Body Irradiation 4Stem Cell Transplantation 4Antibodies 4thymoglobulin 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Antilymphocyte Serum 3Alemtuzumab 3Tacrolimus 2Methotrexate 2Busulfan 2treosulfan 1sargramostim 1merphos 1fludarabine 1bryostatin 1 1X-Rays 1Transplantation, Homologous 1Thiotepa 1Rituximab 1Muromonab-CD3 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Drug Therapy 1Cyclosporins 1Cyclosporine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hemoglobinuria, Paroxysmal × Cyclosporins × Clear all
NCT00397813 2020-01-31

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

Fred Hutchinson Cancer Center

Phase 2 Completed
77 enrolled 16 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Hemoglobinuria, Paroxysmal, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡